2014 Taubman Prize Selection Committee Members

 The following individuals comprise the national selection committee that will judge the entries for the 2014 Taubman Prize:

Harry Dietz, M.D.

  • Victor A. McKusick Professor of Genetics and Medicine, Johns Hopkins University

  • Howard Hughes Medical Institute Investigator

  • 2012 Taubman Prize Recipient

 

David Ginsburg, M.D.

  • James V. Neel Distinguished Professor of Internal Medicine and Human Genetics, University of Michigan Medical School
  • Howard Hughes Medical Institute Investigator

 

William N. Kelley, M.D.

  • Professor of Medicine, University of Pennsylvania School of Medicine

 

Gary Koretzky, M.D., Ph.D.

  • Dean, Weill Cornell Graduate School, Cornell University
  • Senior Associate Dean for Research and Professor, Weill Cornell Medical College
  • Frank H.T. Rhodes Distinguished Professor in Cardiovascular Biology and Genetics

 

Elizabeth G. Nabel, M.D.

  • President, Brigham and Women’s / Faulkner Hospitals

 

David G. Nathan, M.D.

  • Professor of Medicine, Harvard Medical School

 

David C. Page, M.D.

  • Director, Whitehead Institute
  • Professor of Biology, Massachusetts Institute of Technology
  • Howard Hughes Medical Institute Investigator

 

Charles L. Sawyers,  M.D.

  • Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
  • Marie-Josee and Henry R. Kravis Chair
  • Howard Hughes Medical Institute Investigator

 

Barbara Vickrey, M.D., M.P.H.

  • Vice Chair, Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles

 

Tachi Yamada, M.D.

  • Executive Vice President, Chief Medical and Scientific Officer
  • Takeda Pharmaceutical Co.

 

 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists